Long-term risk of atherosclerotic cardiovascular disease in US adults with the familial hypercholesterolemia phenotype

Circulation

Volumn 134, Issue 1, 2016, Pages 9-19

  Perak, Amanda M ^a,b   Ning, Hongyan ^b   De Ferranti, Sarah D ^c   Gooding, Holly C ^c   Wilkins, John T ^b   Lloyd Jones, Donald M ^b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

coronary disease; epidemiology; hypercholesterolemia

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SAMPLE SIZE; UNITED STATES; ATHEROSCLEROSIS; BLOOD; COHORT ANALYSIS; COMPLICATION; GENETICS; GENOTYPE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK; YOUNG ADULT;

ADULT; AGED; ATHEROSCLEROSIS; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; GENOTYPE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK; UNITED STATES; YOUNG ADULT;

EID: 84977260322     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.022335     Document Type: Article

References (41)

1. de Ferranti SD, Rodday AM, Mendelson MM, Wong JB, Leslie LK, Sheldrick RC, Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES). Circulation 2016 133 1067 1072. doi: 10.1161/CIRCULATIONAHA.115.018791.
2. Knowles JW, O'Brien EC, Greendale K, Wilemon K, Genest J, Sperling LS, Neal WA, Rader DJ, Khoury MJ, Reducing the burden of disease and death from familial hypercholesterolemia: a call to action. Am Heart J 2014 168 807 811. doi: 10.1016/j.ahj.2014.09.001.
3. Do R, Stitziel NO, Won HH, Jørgensen AB, Duga S, Angelica Merlini P, Kiezun A, Farrall M, Goel A, Zuk O, Guella I, Asselta R, Lange LA, Peloso GM, Auer PL, Girelli D, Martinelli N, Farlow DN, DePristo MA, Roberts R, Stewart AF, Saleheen D, Danesh J, Epstein SE, Sivapalaratnam S, Hovingh GK, Kastelein JJ, Samani NJ, Schunkert H, Erdmann J, Shah SH, Kraus WE, Davies R, Nikpay M, Johansen CT, Wang J, Hegele RA, Hechter E, Marz W, Kleber ME, Huang J, Johnson AD, Li M, Burke GL, Gross M, Liu Y, Assimes TL, Heiss G, Lange EM, Folsom AR, Taylor HA, Olivieri O, Hamsten A, Clarke R, Reilly DF, Yin W, Rivas MA, Donnelly P, Rossouw JE, Psaty BM, Herrington DM, Wilson JG, Rich SS, Bamshad MJ, Tracy RP, Cupples LA, Rader DJ, Reilly MP, Spertus JA, Cresci S, Hartiala J, Tang WH, Hazen SL, Allayee H, Reiner AP, Carlson CS, Kooperberg C, Jackson RD, Boerwinkle E, Lander ES, Schwartz SM, Siscovick DS, McPherson R, Tybjaerg-Hansen A, Abecasis GR, Watkins H, Nickerson DA, Ardissino D, Sunyaev SR, O'Donnell CJ, Altshuler D, Gabriel S, Kathiresan S, NHLBI Exome Sequencing Project Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature 2015 518 102 106. doi: 10.1038/nature13917.
4. Versmissen J, Oosterveer DM, Yazdanpanah M, Defesche JC, Basart DC, Liem AH, Heeringa J, Witteman JC, Lansberg PJ, Kastelein JJ, Sijbrands EJ, Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. BMJ 2008 337 a2423
5. Scientific Steering Committee, Simon Broome Register Group Mortality in treated heterozygous familial hypercholesterolaemia. Atherosclerosis 1999 142 105 112
6. Neil A, Cooper J, Betteridge J, Capps N, McDowell I, Durrington P, Seed M, Humphries SE, Reductions in all-cause, cancer, and coronary mortality in statin-Treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008 29 2625 2633. doi: 10.1093/eurheartj/ehn422.
7. Barkas F, Elisaf M, Milionis H, Statins decrease the risk of stroke in individuals with heterozygous familial hypercholesterolemia: a systematic review and meta-Analysis. Atherosclerosis 2015 243 60 64. doi: 10.1016/j.atherosclerosis.2015.08.038.
8. Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Borén J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjærg-Hansen A, European Atherosclerosis Society Consensus Panel Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013 34 3478 3490a. doi: 10.1093/eurheartj/eht273.
9. deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW, Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States [published online ahead of print March 24, 2016]. Circ Cardiovasc Genet. doi: 10.1161/CIRCGENETICS.116.001381. http://circgenetics.ahajournals.org/content/early/2016/03/18/CIRCGENETICS.116.001381.long. Accessed May 13, 2016.
10. Knowles JW, Stone NJ, Ballantyne CM, Familial hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association guidelines: myths, oversimplification, and misinterpretation versus facts. Am J Cardiol 2015 116 481 484. doi: 10.1016/j.amjcard.2015.04.062.
11. Williams RR, Hasstedt SJ, Wilson DE, Ash KO, Yanowitz FF, Reiber GE, Kuida H, Evidence that men with familial hypercholesterolemia can avoid early coronary death: an analysis of 77 gene carriers in four Utah pedigrees. JAMA 1986 255 219 224
12. Jensen J, Blankenhorn DH, Kornerup V, Coronary disease in familial hypercholesterolemia. Circulation 1967 36 77 82
13. Sijbrands EJ, Westendorp RG, Defesche JC, de Meier PH, Smelt AH, Kastelein JJ, Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. BMJ 2001 322 1019 1023
14. Scientific Steering Committee, Simon Broome Register Group Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 1991 303 893 896
15. Slack J, Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. Lancet 1969 2 1380 1382
16. Krogh HW, Mundal L, Holven KB, Retterstøl K, Patients with familial hypercholesterolaemia are characterized by presence of cardiovascular disease at the time of death. Eur Heart J 2016 37 1398 1405. doi: 10.1093/eurheartj/ehv602.
17. Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG, Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 2012 97 3956 3964. doi: 10.1210/jc.2012-1563.
18. Stone NJ, Levy RI, Fredrickson DS, Verter J, Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 1974 49 476 488
19. Austin MA, Hutter CM, Zimmern RL, Humphries SE, Familial hypercholesterolemia and coronary heart disease: a HuGE association review. Am J Epidemiol 2004 160 421 429. doi: 10.1093/aje/kwh237.
20. Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW, McCrindle B, Raal F, Rader D, Santos RD, Lopes-Virella M, Watts GF, Wierzbicki AS, American Heart Association Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Cardiometabolic Health The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association. Circulation 2015 132 2167 2192. doi: 10.1161/CIR.0000000000000297.
21. Hopkins PN, Toth PP, Ballantyne CM, Rader DJ, National Lipid Association Expert Panel on Familial Hypercholesterolemia Familial hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011 5 suppl S9 S17. doi: 10.1016/j.jacl.2011.03.452.
22. World Health Organization Familial Hypercholesterolemia 1998 Geneva, Switzerland World Health Organization
23. Wilkins JT, Karmali KN, Huffman MD, Allen NB, Ning H, Berry JD, Garside DB, Dyer A, Lloyd-Jones DM, Data resource profile: the Cardiovascular Disease Lifetime Risk Pooling Project. Int J Epidemiol 2015 44 1557 1564. doi: 10.1093/ije/dyv150.
24. Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, Greenland P, Van Horn L, Tracy RP, Lloyd-Jones DM, Lifetime risks of cardiovascular disease. N Engl J Med 2012 366 321 329. doi: 10.1056/NEJMoa1012848.
25. Dawber TR, Kannel WB, Lyell LP, An approach to longitudinal studies in a community: the Framingham study. Ann N Y Acad Sci 1963 107 539 556
26. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP, The Framingham Offspring Study: design and preliminary data. Prev Med 1975 4 518 525
27. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, The Cardiovascular Health Study: design and rationale. Ann Epidemiol 1991 1 263 276
28. ARIC Investigators The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1989 129 687 702
29. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Savage PJ, CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988 41 1105 1116
30. National Center for Health Statistics Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Vital Health Stat 1994 1 1 407
31. Office of Analysis and Epidemiology The Third National Health and Nutrition Examination Survey (NHANES III) Linked Mortality File, Mortality Follow-Up Through 2006. 2009 Hyattsville, MD National Center for Health Statistics
32. Friedewald WT, Levy RI, Fredrickson DS, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 499 502
33. Murabito JM, Nam BH, D'Agostino RB Sr, Lloyd-Jones DM, O'Donnell CJ, Wilson PW, Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med 2004 140 434 440
34. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 2016 133 e38 e360. doi: 10.1161/CIR.0000000000000350.
35. Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, Hopkins PN, Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 1993 72 171 176
36. CARDIA Endpoints Surveillance and Adjudication Committee. CARDIA endpoint events manual of operations. http://www.cardia.dopm.uab.edu/images/more/pdf/MM-endpoints-followup/MM-endpoints/CARDIA%20Endpoint%20Events%20MOO%20v2014-06-30.pdf. 2014. Accessed March 1, 2016.
37. Abbott R, McGee D, The Framingham Study 1987 Bethesda, MD National Heart, Lung, and Blood Institute
38. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R, Blood cholesterol and vascular mortality by age, sex, and blood pressure. Lancet 2007 370 1829 1839
39. Sniderman AD, Tsimikas S, Fazio S, The severe hypercholesterolemia phenotype: clinical diagnosis, management, and emerging therapies. J Am Coll Cardiol 2014 63 1935 1947. doi: 10.1016/j.jacc.2014.01.060.
40. Goldberg AC, Robinson JG, Cromwell WC, Ross JL, Ziajka PE, Future issues, public policy, and public awareness of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011 5 suppl S46 S51. doi: 10.1016/j.jacl.2011.04.002.
41. Goldman RE, Parker DR, Eaton CB, Borkan JM, Gramling R, Cover RT, Ahern DK, Patients' perceptions of cholesterol, cardiovascular disease risk, and risk communication strategies. Ann Fam Med 2006 4 205 212. doi: 10.1370/afm.534.